Magellan(MAGE)
Focus: Magellan is a publicly traded biotechnology company focused on stem cell-derived therapies for musculoskeletal and cell therapy indications, headquartered in Wallace, ID with 85 active job openings.
Profile data last refreshed 3h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
242-15 this month
Cooling — net -15 jobs in 30d
98 added, 113 removed. Slower than typical.
Should You Work at Magellan?
AI assessmentHigh-risk, early-stage public biotech bet suitable only for risk-tolerant candidates willing to join a company facing acute financial stress but holding a potentially valuable stem cell asset.
Why Work Here
- Leading late-stage pipeline with allogeneic mesenchymal stem cell therapy in Phase 3 for knee osteoarthritis, a large market opportunity
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Mightier video games
Emotional DysregulationClinical Trials (1)
NCT04732806A Mightier Healthcare System
N/AHelp build intelligence for Magellan
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.